The ELEVATE-TIMI 56 ( Escalating Clopidogrel by Involving a Genetic Strategy-Thrombolysis In Myocardial Infarction 56 ) investigators genotyped 333 patients with coronary artery disease and randomized them to various clopidogrel regimens .